In focus · trending topic

Surface Oncology

1 stories · following the connections

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and Antibody License Option Agreement with Surface Oncology

By Nasdaq OMXJan 8, 2018, 6:10 PM UTC